PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1525258
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1525258
The global wireless cardiac monitoring systems market was valued at USD 2.98 billion in 2023 and is expected to grow at a CAGR of 11.4% from 2024 to 2032. Wireless cardiac monitoring systems, comprising wearable sensors and mobile apps, continuously monitor a patient's heart activity and wirelessly transmit the data to healthcare providers. These systems are pivotal in detecting arrhythmias, managing chronic heart conditions, and monitoring post-surgical recovery, thus improving patient outcomes and minimizing the need for frequent hospital visits.
The market is poised for significant growth due to an aging population susceptible to cardiovascular diseases (CVDs), technological advancements in remote monitoring technologies, and increasing product approvals in developed economies. For instance, the British Heart Foundation reported that the prevalence of heart & circulatory diseases globally was 620 million in 2021, with atrial fibrillation accounting for approximately 10% of these cases. Innovations in remote patient monitoring technology are expected to propel the market forward. Industry players are forming strategic alliances, such as funding and collaborations, to develop vendor-neutral cardiac data management platforms. These platforms enable the monitoring of medical information from implantable cardiac monitors (ICM), wearable devices, consumer ECG devices, and more. Moreover, integrating artificial intelligence (AI) into these platforms, which synchronizes electronic health records and identifies urgent patient reports and critical heart rhythms, is expected to drive market growth. For example, in July 2023, PaceMate, a remote cardiac monitoring service provider, secured investment from Lead Edge Capital to enhance its cardiac solutions and demographic reach.
North America dominated the global wireless cardiac monitoring systems market, accounting for 48.53% of the total market share in 2023. This dominance is attributed to the region's advanced healthcare infrastructure, high prevalence of cardiovascular diseases, rapid technological advancements, substantial healthcare expenditure, and an increasing geriatric population. According to the Rural Health Information Hub, the U.S. geriatric population is expected to rise by 18 million between 2020-2030, with 90% of adults over 65 developing one or more chronic conditions. Moreover, Asia-Pacific is projected to witness the fastest CAGR of 13.5% over the forecast period. The growth is driven by increasing product approvals in countries like China and Japan. For instance, in January 2020, Biotronik SE & Co. KG launched its implantable cardiac monitor (ICM), BioMonitor III, in Japan to help healthcare professionals identify underlying arrhythmias. Similarly, in October 2021, Shanghai Chest Hospital launched an ICM to enhance ECG monitoring & symptom correlation for Chinese patients.